Pasithea Therapeutics Corp. (NASDAQ:KTTA – Get Free Report)’s share price was up 2.4% on Friday . The company traded as high as $3.42 and last traded at $3.38. Approximately 23,741 shares changed hands during mid-day trading, a decline of 92% from the average daily volume of 286,469 shares. The stock had previously closed at $3.30.
Pasithea Therapeutics Stock Up 2.4 %
The business’s 50 day simple moving average is $4.25 and its two-hundred day simple moving average is $5.08.
Pasithea Therapeutics (NASDAQ:KTTA – Get Free Report) last announced its quarterly earnings results on Tuesday, August 13th. The company reported ($3.71) earnings per share for the quarter.
About Pasithea Therapeutics
Pasithea Therapeutics Corp., a biotechnology company, engages in discovery, research, and development of treatments for central nervous system disorders, RASopathies, and other diseases. Its lead product candidate PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor for use in the treatment of a range of RASopathies, including neurofibromatosis type 1 oncology indications.
Recommended Stories
- Five stocks we like better than Pasithea Therapeutics
- Where Do I Find 52-Week Highs and Lows?
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- The Most Important Warren Buffett Stock for Investors: His Own
- Top-Performing Non-Leveraged ETFs This Year
- Are Penny Stocks a Good Fit for Your Portfolio?
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Pasithea Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pasithea Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
